SUBSCRIBE
SUBSCRIBE
News   Policy

CBER: Blood Products Advisory Committee Meeting

August 12, 2008 | 
1 min read

Blood Products Advisory Committee Meeting agenda posted 8/12/2008; Meeting Date: 9/10-11/2008.

Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
White house with pills and medicines, capsules
Opinion
How To Bring Generic Drug Manufacturing Back to the US
September 30, 2025
 · 
5 min read
 · 
Vic Suarez
Illustration showing woman starting down curved path with markers toward goal marked by flag
Rare diseases
New Confirmatory Study Hints at ‘Alignment’ Between Applied Therapeutics, FDA for Rare Disease Drug
September 29, 2025
 · 
2 min read
 · 
Tristan Manalac
Protection From Tariffs as an An umbrella that shields against import and export tariff taxes as a trade war storm increasing prices and straining supply chains as a business metaphor and a symbol for resilience in times of crisis and economic downturn.
Tariffs
Trump Sets 100% Pharma Tariff Deadline for October 1
September 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Stack of coins balancing on seesaw over a bottle of pills.
Drug pricing
Trump Admin Readies Proposed Rule To Lower US Drug Prices
September 26, 2025
 · 
2 min read
 · 
Tristan Manalac